Sarepta's drug improves walking ability in trial, shares soar

(Reuters) - Sarepta Therapeutics Inc said its experimental drug met the main goal of improving walking ability in patients with a rare muscle disorder in a mid-stage trial, sending its shares up 111 percent in premarket trade. The drug eteplirsen ...

Source: http://health.yahoo.net/news/s/nm/sarepta-s-drug-improves-walking-ability-in-trial-shares-soar

Medal of Honor Lion King The Vampire Diaries Grand Slam